<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>46(2)</volume><submitter>Alves C</submitter><funding>Universidade de Coimbra</funding><funding>Tecnimede, SA</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Ibandronate is effective in reducing the risk of vertebral fractures, but experimental evidence offers conflicting results regarding nonvertebral fractures. Real-world evidence has been published evaluating the anti-nonvertebral fracture effect of ibandronate.&lt;h4>Aim&lt;/h4>This meta-analysis of observational studies assessed the effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis.&lt;h4>Method&lt;/h4>Pubmed/Embase databases were searched for observational studies. Risks of nonvertebral fractures and hip fractures were the outcomes. Meta-analyses were performed pooling rate ratios (RRs), using random-effects models. Data were reanalysed in sensitivity analyses considering Knapp-Hartung method and Bayesian random-effects.&lt;h4>Resul</pubmed_abstract><journal>International journal of clinical pharmacy</journal><pagination>357-367</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10960777</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies.</pubmed_title><pmcid>PMC10960777</pmcid><pubmed_authors>Penedones A</pubmed_authors><pubmed_authors>Alves C</pubmed_authors><pubmed_authors>Batel-Marques F</pubmed_authors><pubmed_authors>Mendes D</pubmed_authors><pubmed_authors>Oliveira T</pubmed_authors><pubmed_authors>Donato A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies.</name><description>&lt;h4>Background&lt;/h4>Ibandronate is effective in reducing the risk of vertebral fractures, but experimental evidence offers conflicting results regarding nonvertebral fractures. Real-world evidence has been published evaluating the anti-nonvertebral fracture effect of ibandronate.&lt;h4>Aim&lt;/h4>This meta-analysis of observational studies assessed the effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis.&lt;h4>Method&lt;/h4>Pubmed/Embase databases were searched for observational studies. Risks of nonvertebral fractures and hip fractures were the outcomes. Meta-analyses were performed pooling rate ratios (RRs), using random-effects models. Data were reanalysed in sensitivity analyses considering Knapp-Hartung method and Bayesian random-effects.&lt;h4>Resul</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-07-15T20:04:54.419Z</modification><creation>2026-07-09T03:10:17.388Z</creation></dates><accession>S-EPMC10960777</accession><cross_references><pubmed>38112890</pubmed><doi>10.1007/s11096-023-01666-x</doi></cross_references></HashMap>